Literature DB >> 2817117

ECT and Parkinson's disease revisited: a "naturalistic" study.

R Douyon1, M Serby, B Klutchko, J Rotrosen.   

Abstract

In an open study, seven patients with Parkinson's disease received ECT for major depression. Both the motor dysfunction and the mood impairment of these patients improved following an average of seven ECT sessions. Significant improvement in motor function occurred after only two treatments. All aspects of Parkinson's disease improved significantly after ECT. Older patients showed greater improvement in motor function. The authors conclude that the therapeutic utility of ECT in depressed and nondepressed patients with Parkinson's disease should be further evaluated.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2817117     DOI: 10.1176/ajp.146.11.1451

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  19 in total

Review 1.  Psychiatry.

Authors:  K Granville-Grossman
Journal:  Postgrad Med J       Date:  1990-09       Impact factor: 2.401

Review 2.  Non-invasive brain stimulation for Parkinson's disease: a systematic review and meta-analysis of the literature.

Authors:  F Fregni; D K Simon; A Wu; A Pascual-Leone
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-12       Impact factor: 10.154

3.  Management of parkinsonism and psychotic depression in a case of acute intermittent porphyria.

Authors:  P F Chinnery; N E Cartlidge; D J Burn; P G Cleland; I McKeith
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-05       Impact factor: 10.154

4.  Elevated dopamine D1 receptor availability in striatum of Göttingen minipigs after electroconvulsive therapy.

Authors:  Anne M Landau; Aage Ko Alstrup; Helene Audrain; Steen Jakobsen; Mette Simonsen; Arne Møller; Poul Videbech; Gregers Wegener; Albert Gjedde; Doris J Doudet
Journal:  J Cereb Blood Flow Metab       Date:  2017-05-16       Impact factor: 6.200

Review 5.  Depression in Parkinson's disease. Pharmacological characteristics and treatment.

Authors:  T Tom; J L Cummings
Journal:  Drugs Aging       Date:  1998-01       Impact factor: 3.923

Review 6.  Transcranial magnetic stimulation for the treatment of depression in neurologic disorders.

Authors:  Felipe Fregni; Alvaro Pascual-Leone
Journal:  Curr Psychiatry Rep       Date:  2005-10       Impact factor: 5.285

Review 7.  Neuropsychiatric adverse effects of antiparkinsonian drugs. Characteristics, evaluation and treatment.

Authors:  B K Young; R Camicioli; L Ganzini
Journal:  Drugs Aging       Date:  1997-05       Impact factor: 3.923

8.  Electroconvulsive therapy for the physical signs of Parkinson's disease without depressive disorder.

Authors:  S Pridmore; P T Yeo; M I Pasha
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-05       Impact factor: 10.154

9.  Electroconvulsive shock does not modify striatal contents of dopamine in MPTP-treated mice.

Authors:  E Garcia; J Sotelo
Journal:  Neurochem Res       Date:  1993-05       Impact factor: 3.996

10.  Acceptability of electroconvulsive therapy to patients with Parkinson's disease.

Authors:  K Ismail; R Howard; S Lovestone
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-03       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.